International Orphan Drug Approvals: 1D09C3 and Nexavar

The EU has approved orphan drug status for a human monoclonal antibody against human leukocyte antigen-DR (1D09C3) and for sorafenib tosylate tablets (Nexavar).
Medscape Medical News
Yael Waknine